Atea Pharmaceuticals (AVIR) Earnings Date & Reports

Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AVIR is expected to report earnings to rise 6.67% to -42 cents per share on August 06

Atea Pharmaceuticals AVIR Stock Earnings Reports

Q2'25

Est.

$-0.43

Q1'25

Beat

by $0.01

Q4'24

Missed

by $0.05

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.18

The last earnings report on May 12 showed earnings per share of -40 cents, beating the estimate of -40 cents. With 343.01K shares outstanding, the current market capitalization sits at 243.90M.

View a ticker or compare two or three

Compare

AVIR